HLA-C and severe combined immunodeficiency: Defective expression of major histocompatibility complex class II (MHC) molecules accounted for 5% of severe combined immunodeficiency (SCID) in Canadian Survey and almost 20–30% of SCID cases in Kuwait and North Africa (27).